SEC Form D · filed September 12, 2023
LIPELLA PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Naoki Yoshimura · Pittsburgh, PADirectorJonathan Kaufman · Pittsburgh, PAExec · DirectorDouglas Johnston · Pittsburgh, PAExecDaniel Cohen · Pittsburgh, PADirectorMichael Chancellor · Pittsburgh, PAExec · DirectorRyan Pruchnic · Pittsburgh, PADirectorLori Birder · Pittsburgh, PADirectorByong Kim · Pittsburgh, PADirectorJonathan Kaufman · Pittsburgh, PAExec · DirectorDaniel Cohen · Pittsburgh, PADirectorByong Kim · Pittsburgh, PADirectorDouglas Johnston · Pittsburgh, PAExecRyan Pruchnic · Pittsburgh, PADirectorMichael Chancellor · Pittsburgh, PAExec · DirectorNaoki Yoshimura · Pittsburgh, PADirectorLori Birder · Pittsburgh, PADirectorTodd Fein · RENO, NVExecMark Watson · RENO, NVExec · DirectorDouglas Willmore · RENO, NVDirectorJeff Nuss · RENO, NVDirectorChris Wedding · RENO, NVExec · DirectorAllan English · RENO, NVDirectorAlexander Bhathal · Newport Beach, CADirectorChris Marsh · Newport Beach, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗